| |
How do we test for HCV RAVs?
A Technology Based Presentation / Mixed Infections
|
| |
| |
Genotype-Independent Near Whole Genome
Next Generation Assays for HCV Resistance
Evaluation
"Random Primer NGS provides an agnostic approach to
interrogate potential mixed-infections"
Anita Howe, Ph.D.
Centre for Excellence in HIV/AIDS
British Columbia, Canada
http://regist2.virology-education.com/2016/14EU/22_Howe.pdf
|
|
| |
| |
|
|
|
